RedHill Biopharma Ltd.
RDHL
←Back to Recent Filings

Filing DATE FP FY End Date URL VIEW
WIREPR 9/5/2025 Q2 2025 6/30/2025 WIRE view data
6-K 9/5/2025 Q2 2025 6/30/2025 SEC view
6-K/A 9/5/2025 Q2 2025 6/30/2025 SEC view
20-F 4/11/2025 Q4 2024 12/31/2024 SEC view
WIREPR 4/10/2025 Q4 2024 12/31/2024 WIRE view data
WIREPR 8/29/2024 Q2 2024 6/30/2024 WIRE view data
6-K 8/29/2024 Q2 2024 6/30/2024 SEC view
WIREPR 4/8/2024 Q4 2023 12/31/2023 WIRE view data
20-F 4/8/2024 Q4 2023 12/31/2023 SEC view
WIREPR 8/17/2023 Q2 2023 6/30/2023 WIRE view data
6-K 8/17/2023 Q2 2023 6/30/2023 SEC view
WIREPR 6/12/2023 Q1 2023 3/31/2023 WIRE view data
WIREPR 4/28/2023 Q4 2022 12/31/2022 WIRE view data
20-F 4/28/2023 Q4 2022 12/31/2022 SEC view
WIREPR 11/29/2022 Q3 2022 9/30/2022 WIRE view data
WIREPR 11/7/2022 Q2 2022 6/30/2022 WIRE view data
6-K 11/7/2022 Q2 2022 6/30/2022 SEC view
WIREPR 6/23/2022 Q1 2022 3/31/2022 WIRE view data
WIREPR 3/17/2022 Q4 2021 12/31/2021 WIRE view data
20-F 3/17/2022 Q4 2021 12/31/2021 SEC view
WIREPR 11/30/2021 Q3 2021 9/30/2021 WIRE view data
WIREPR 8/30/2021 Q2 2021 6/30/2021 WIRE view data
WIREPR 8/30/2021 Q2 2021 6/30/2021 WIRE view data
WIREPR 8/30/2021 Q2 2021 6/30/2021 WIRE view data
WIREPR 8/26/2021 Q2 2021 6/30/2021 WIRE view data
6-K 8/26/2021 Q2 2021 6/30/2021 SEC view
WIREPR 5/27/2021 Q1 2021 3/31/2021 WIRE view data
WIREPR 3/18/2021 Q4 2020 12/31/2020 WIRE view data
20-F 3/18/2021 Q4 2020 12/31/2020 SEC view
WIREPR 11/12/2020 Q3 2020 9/30/2020 WIRE view data
WIREPR 8/13/2020 Q2 2020 6/30/2020 WIRE view data
6-K 8/13/2020 Q2 2020 6/30/2020 SEC view
WIREPR 5/27/2020 Q1 2020 3/31/2020 WIRE view data
20-F 3/4/2020 Q4 2019 12/31/2019 SEC view
WIREPR 11/19/2019 Q4 2019 12/31/2019 WIRE view data
WIREPR 7/23/2019 Q2 2019 6/30/2019 WIRE view data
6-K 7/23/2019 Q2 2019 6/30/2019 SEC view
WIREPR 2/26/2019 Q4 2018 12/31/2018 WIRE view data
20-F 2/26/2019 Q4 2018 12/31/2018 SEC view
WIREPR 11/13/2018 Q3 2018 9/30/2018 WIRE view data
WIREPR 8/30/2018 Q2 2018 6/30/2018 WIRE view data
6-K 8/30/2018 Q2 2018 6/30/2018 SEC view
20-F 2/22/2018 Q4 2017 12/31/2017 SEC view